Table 1. Demographic features and clinical characteristics of the study groups.

	Glaucoma	Control	Significance (P)
Number of eyes	36	18
Age, year	68±11 (51 to 88)	66±6 (52 to 74)	0.4
Gender, female	16 (44%)	8 (44%)	1
24–2 Visual field mean deviation, dB	-9.05±10.85 (-1.65 to -26.83)	0.23±1.01 (2.06 to -1.12)	<0.001
<-5.00 dB	11 (31%)	18 (100%)
-5.01–12.00 dB	14 (39%)	-
>-12.00 dB	11 (31%)	-
IOP, mmHg	12.83±3.09 (9 to 18)	12.78±2.69 (10 to 17)	0.9
Number of IOP-lowering medications	2.20±0.82 (1 to 3)	-
Type of IOP-lowering medications
alpha-adrenergic agonists	15 (42%)
beta-adrenergic blockers	14 (39%)
carbonic anhydrase inhibitors	16 (44%)
prostaglandin analogs	18 (50%)

Data are presented as mean±SD (range) when applicable.